Sol-Gel Technologies (SLGL) Short-term Investments (2016 - 2025)
Sol-Gel Technologies (SLGL) posted quarterly Short-term Investments of $13.0 million for Q4 2025, up 193.02% year-over-year from $4.4 million in Q4 2024, and down 7.74% quarter-over-quarter from $14.1 million in Q2 2025.
Sol-Gel Technologies (SLGL) Short-term Investments (2016 - 2025) Analysis & Trends
Sol-Gel Technologies (SLGL) has reported Short-term Investments for 10 consecutive years, with $13.0 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Short-term Investments rose 193.02% year-over-year to $13.0 million; the TTM figure through Dec 2025 stood at $13.0 million (up 193.02% YoY), while the FY2025 annual figure was $13.0 million, up 193.02% from the prior year.
- Short-term Investments slipped to $13.0 million in Q4 2025 per SLGL's latest filing, from $14.1 million in the prior quarter.
- Across five years, Short-term Investments topped out at $21.0 million in Q2 2022 and bottomed at $1.7 million in Q4 2021.
- Historically, Short-term Investments has averaged $13.7 million across 5 years, with a median of $14.5 million in 2024.
- Annual changes were most pronounced in 2021 — Short-term Investments plunged 92.11% — and 2022, when it jumped 407.78%.
- Sol-Gel Technologies' Short-term Investments stood at $1.7 million in 2021, then surged by 407.78% to $8.7 million in 2022, then soared by 135.9% to $20.5 million in 2023, then tumbled by 78.38% to $4.4 million in 2024, then soared by 193.02% to $13.0 million in 2025.
- Business Quant data shows SLGL's Short-term Investments at $13.0 million in Q4 2025, $14.1 million in Q2 2025, and $4.4 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Sol-Gel Technologies | 240.26 Mn | 230.12 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 12.97 Mn |
| Jun 30, 2025 | 14.05 Mn |
| Dec 31, 2024 | 4.43 Mn |
| Jun 30, 2024 | 14.91 Mn |
| Dec 31, 2023 | 20.47 Mn |
| Jun 30, 2023 | 17.86 Mn |
| Dec 31, 2022 | 8.68 Mn |
| Jun 30, 2022 | 21.00 Mn |
| Dec 31, 2021 | 1.71 Mn |
| Jun 30, 2021 | 20.90 Mn |
| Dec 31, 2020 | 21.65 Mn |
| Jun 30, 2020 | 40.68 Mn |
| Dec 31, 2019 | 40.97 Mn |
| Jun 30, 2019 | 35.52 Mn |
| Dec 31, 2018 | 56.66 Mn |
| Sep 30, 2018 | 122,000.00 |
| Jun 30, 2018 | 72,000.00 |
| Dec 31, 2017 | 13,000.00 |
| Dec 31, 2016 | 823,000.00 |